API Melphalan Hydrochloride GMP Multiple Myeloma Treatment
Contact Person : Jimmy Tian
Phone Number : 86-18602905046
WhatsApp : +8618602905046
Minimum Order Quantity : | 100g | Packaging Details : | About 500g in an aluminum bag |
---|---|---|---|
Delivery Time : | 30 days | Payment Terms : | T/T, L/C |
Supply Ability : | 1000 kg / year |
Place of Origin: | China | Brand Name: | LIBANG |
---|---|---|---|
Certification: | Chinese GMP |
Detail Information |
|||
Quality Specification: | In-house | Dossier: | DMF To Be Filed |
---|---|---|---|
Storage: | Store At 2~8℃ | Batch Size: | Approx.800g |
Country Of Origin: | China | Indication: | Reversal Of The Sedation Of Medetomidine In Pets |
High Light: | Pharmaceutical Grade Atipamezole HCL,Atipamezole HCL CAS 104075-48-1,104075-48-1 Atipamezole Hydrochloride |
Product Description
Atipamezole HCL Pharmaceutical Grade
Melphalan hydrochloride is approved to treat:
Multiple myeloma.
It is used for palliative treatment in patients who cannot take melphalan by mouth. This use is approved for the Alkeran and Evomela brands.
It is used as a conditioning treatment to prepare patients for a stem cell transplant. This use is approved for the Evomela brand.
Melphalan hydrochloride is also being studied in the treatment of other types of cancer.
Chemical Name: Atipamezole HCl
CAS No.:104075-48-1
Molecular Formula: C14H16N2.HCl
Molecular weight: 248.75
Appearance: White powder
ITEMS | SPECIFICATION | TESTRESULTS |
Appearance | Off-white or white powder | Conforms |
Identification | HPLC,NMR;LC-MS | Conforms |
Related substances | Individual impurity≤0.5% | 0.09% |
Total impurities≤1.0% | 0.20% | |
Loss on drying | ≤0.5% | 0.3% |
Residue on ignition | ≤0.1% | 0.04% |
Heavy metals | ≤10ppm | Conforms |
Assay | ≥98.0 % | 99.1% |
Atipamezole HCl Packaging & Shipping
Shipping : within 20 days after receive your payment
Packaging : According to customer requirement
Xi`an Libang Pharmaceu>cal Co., Ltd, since 1996, located in Xi`an city, P.R. China, specialized in researching, produc>on and distribu>on of Finished pharmaceu>cal products and APIs. A Leading player of Lipid-based Drug Delivery System in China With two decades of rapid growth, ranks in the Top 100 China’ s Pharmaceu>cal Industries for 6 consecu>ve years and also listed in the Top 20 The Most Poten>al Chinese Pharmaceu>cals rated by the IMS Health.
Enter Your Message